| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.97B | 35.30B | 31.41B | 21.83B | 20.62B | 20.02B |
| Gross Profit | 11.08B | 7.96B | 11.23B | 5.74B | 5.37B | 4.71B |
| EBITDA | 8.88B | 7.34B | 8.91B | 4.02B | 3.88B | 4.04B |
| Net Income | 2.57B | 216.02M | 2.94B | 651.72M | 666.55M | 275.45M |
Balance Sheet | ||||||
| Total Assets | 81.00B | 82.45B | 81.60B | 30.38B | 26.37B | 28.52B |
| Cash, Cash Equivalents and Short-Term Investments | 24.25B | 15.39B | 29.49B | 5.26B | 4.81B | 5.45B |
| Total Debt | 21.81B | 35.83B | 23.66B | 12.41B | 9.56B | 11.55B |
| Total Liabilities | 51.18B | 52.12B | 51.34B | 21.06B | 17.88B | 20.07B |
| Stockholders Equity | 29.61B | 30.10B | 30.06B | 9.14B | 8.35B | 8.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -30.11B | -11.87B | -597.67M | 3.47B | 2.66B |
| Operating Cash Flow | 0.00 | 6.22B | 5.79B | 2.88B | 3.96B | 3.96B |
| Investing Cash Flow | 0.00 | -24.64B | -8.32B | -2.03B | -606.13M | -1.67B |
| Financing Cash Flow | 0.00 | 4.32B | 26.76B | -410.59M | -4.00B | -1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥24.56B | 11.47 | ― | ― | 13.54% | 54.38% | |
68 Neutral | ¥15.83B | -40.95 | ― | ― | 12.01% | -191.28% | |
68 Neutral | ¥33.64B | 13.76 | ― | 0.39% | 22.45% | 23.34% | |
65 Neutral | ¥9.72B | 23.89 | ― | 2.16% | -1.76% | 25.65% | |
62 Neutral | ¥44.67B | 50.91 | ― | ― | 43.11% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | ¥120.14B | 32.36 | ― | 0.14% | 12.38% | -92.66% |